Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Nexeon MedSystems Inc.

This article was originally published in Start Up

Executive Summary

A new coronary stent made of cobalt alloy and coated with a thin layer of protein may provide a welcome alternative to traditional bare-metal or drug-eluting stents. When placed in the body, the prohealing PROTEX coronary stent system from Nexeon MedSystems is recognized by the body as having the architecture of a normal artery. Hence, according to the start-up, the body begins to populate the stent quickly with regular functioning cells, rather than reacting to the stent as a foreign metal. Because the thin, low-profile stent platform is biomimetic, rapid healing should occur.
Advertisement

Related Content

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

MT037538

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel